HUMANIZED monoclonal ANTIBODY, inhibitor of tissue factor-dependent coagulation pathway - concizumab, with successive deliveries to centers for treatment of hemophilia and bleeding disorders - 5097941

World Biggest Tenders Source

This tender with title HUMANIZED monoclonal ANTIBODY, inhibitor of tissue factor-dependent coagulation pathway - concizumab, with successive deliveries to centers for treatment of hemophilia and bleeding disorders - 5097941 has been published on Bidding Source portal dated 26 Oct 2026 for the country of Poland. It has been categorized on Medicinal products for the blood and blood-forming organs. For similar tenders you can see tenders mentioned below of this page.

General Information

Poland

Tender Title :

HUMANIZED monoclonal ANTIBODY, inhibitor of tissue factor-dependent coagulation pathway - concizumab, with successive deliveries to centers for treatment of hemophilia and bleeding disorders - 5097941

Tender Type :

Invitation for Bids

Reference No. :

5097941

Country :

Poland

Publish Date :

26 Oct 2026

Closing Date :

9 Nov 2026

Notice Language :

English

Tender Categories (CPVs) :

Medicinal products for the blood and blood-forming organs

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Awarded - BISPECIFIC ANTIBODY mimicking active factor VIII with successive deliveries to Hemophilia and Related Bleeding Disorders Treatment Centers and patient homes - 5094624 Poland Awarded - Coagulation factor XIII concentrate with delivery to Regional Blood Donation and Blood Treatment Centers; procedure reference: ZZP.ZP.411.118.2026 - 5094687 Poland Awarded - Recombinant coagulation factor IX concentrate, minimum generation, with delivery to Regional Blood Donation and Blood Treatment Centers - 5095680 Poland Recombinant human von Willebrand factor (rVWF) concentrate with delivery to Regional Blood Donation and Blood Treatment Centers. Parts 1-4 - 5099977 Poland Recombinant coagulation factor VIII concentrate with delivery - 8996610 Poland Recombinant coagulation factor IX concentrate, minimum 2nd generation, with delivery to Regional Blood Donation and Blood Treatment Centers; procedure reference: ZZP.ZP.411.159.2026 parts: 1÷2 - 8477624 Poland Awarded - PURCHASE OF INTRAVENOUS DESMOPRESSIN WITH DELIVERY TO REGIONAL BLOOD DONATION AND BLOOD TREATMENT CENTERS; reference number: ZZP.ZP.411.95.2026 - 8475147 Poland Awarded - PURCHASE OF RECOMBINANT COAGULATION FACTOR VIII CONCENTRATE, MINIMUM 2ND GENERATION, WITH DELIVERY TO REGIONAL BLOOD DONATION AND BLOOD TREATMENT CENTERS; reference number: ZZP.ZP.411.96.2026 - 8475164 Poland Recombinant coagulation factor IX concentrate, minimum 2nd generation, with delivery to Regional Blood Donation and Blood Treatment Centers; procedure reference: ZZP.ZP.411.159.2026 parts: 1÷2 Poland Recombinant coagulation factor VIII concentrate, minimum 2nd generation, with delivery to Regional Blood Donation and Blood Treatment Centers; procedure reference: ZZP.ZP.411.158.2026 parts: 1÷2 Poland

HUMANIZED monoclonal ANTIBODY, inhibitor of tissue factor-dependent coagulation pathway - concizumab, with successive deliveries to centers for treatment of hemophilia and bleeding disorders - 5097941

General Information

Poland

Similar Tenders

Medicinal products for the blood and blood-forming organs Tenders

Poland Tenders

Europe Tenders

Tenders

info@biddingsource.com